
Indo Medconsultancy Private Limited
About Indo Medconsultancy Private Limited
Data last updated:
Indo Medconsultancy Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the healthcare services segment of the healthcare sector. It was incorporated on 28 September 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U85100DL2015PTC285704. Its GSTIN is 07AADCI9470J1Z6 (Delhi).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Monica Abrol and Sanjeev Kumar Sharma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. C – 71 Nawada Housing Complex Uttam Nagar, New Delhi, Delhi, India – 110059.
As per the financials filed for FY 2025, the company reported a revenue of ₹32.5 Lakh. For the same year it recorded a net profit of ₹31,479 (net margin 1%) and EBITDA of ₹77,480 (EBITDA margin 2.4%). Revenue has grown at a compounded annual rate (CAGR) of 31% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Indo Medconsultancy Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No. C – 71 Nawada Housing Complex Uttam Nagar, New Delhi, Delhi, India – 110059
- IndustryHealthcare, Human Health Activities
To see the full contact details of Indo Medconsultancy Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Indo Medconsultancy is professional, scientific and technical activities. In detail, this covers other professional, scientific and technical activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, scientific and technical activities | 74 | Other professional, scientific and technical activities |
To see the full business activity and turnover split of Indo Medconsultancy Private Limited, buy the company report.
Financials of Indo Medconsultancy Private Limited
FY 2025 filings availableIndo Medconsultancy Private Limited reported revenue of ₹32.5 Lakh for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 31% over five years. EBITDA fell 85% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹77,480 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹31,479 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.4% | ||||
| Net Profit Margin | 1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Indo Medconsultancy Private Limited, buy the company report.
Board of directors of Indo Medconsultancy Private Limited
Indo Medconsultancy has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Monica Abrol Also directs: Indomed Travels Private Limited | Director | 16 Oct 2017 | 9 Years 0 Months | Current |
| Sanjeev Kumar Sharma Also directs: Indomed Travels Private Limited | Director | 28 Sep 2015 | 11 Years 0 Months | Current |
Shareholding
The shareholding of Indo Medconsultancy Private Limited is on record for FY 2016, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2016 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Indo Medconsultancy Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Indo Medconsultancy Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Indo Medconsultancy Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Indo Medconsultancy has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AADCI9470J1Z6 | Delhi | Active | 28 Aug 2019 |
To see the full GST registrations and return filing status of Indo Medconsultancy Private Limited, buy the company report.
Recent activity
Indo Medconsultancy Private Limited has 3 board changes on record since 2015: 2 appointments and 1 cessation. The latest: Pradeep Kumar Misra ceased to be Director on 30 Jun 2019.
Frequently asked questions
Indo Medconsultancy is an active private limited company based in New Delhi, Delhi, India. The company works in human health activities, within the healthcare industry. It was incorporated on 28 September 2015 (11+ years old) and is registered under CIN U85100DL2015PTC285704.
Indo Medconsultancy has 2 current directors:
- Monica Abrol - Director
- Sanjeev Kumar Sharma - Director
The latest financial statements of Indo Medconsultancy on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Indo Medconsultancy is 07AADCI9470J1Z6, registered in Delhi.
The CIN (Corporate Identification Number) of Indo Medconsultancy is U85100DL2015PTC285704. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Indo Medconsultancy was incorporated on 28 September 2015, making it 11+ years old. It is registered with the Registrar of Companies, Delhi.
Pradeep Kumar Misra ceased to be Director on 30 Jun 2019. Monica Abrol was appointed as Director on 16 Oct 2017. Sanjeev Kumar Sharma was appointed as Director on 28 Sep 2015.
The registered office of Indo Medconsultancy is at Plot No. C – 71 Nawada Housing Complex Uttam Nagar, New Delhi, Delhi, India – 110059.
Indo Medconsultancy operates in the healthcare industry, in the human health activities segment.
The compliance status of Indo Medconsultancy is compliant as of 09 August 2026. The company is actively filing with the Registrar of Companies.